{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"congenital-isolated-hyperinsulinism","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"Congenital isolated hyperinsulinism (CHI), a rare endocrine disease is the most frequent cause of severe and persistent hypoglycemia in the neonatal period and early infancy and is characterized by an excessive or uncontrolled insulin secretion (inappropriate for the level of glycemia) and recurrent episodes of profound hypoglycemia requiring rapid and intensive treatment to prevent neurological sequelae. CHI comprises 2 different forms: diazoxide-sensitive diffuse hyperinsulinism and diazoxide-resistant hyperinsulinism.","mondoId":"MONDO:0019010","node":{"canonicalSlug":"congenital-isolated-hyperinsulinism","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Congenital isolated hyperinsulinism","originalSourceId":"ORPHA:657","paragraphs":["Congenital isolated hyperinsulinism (CHI), a rare endocrine disease is the most frequent cause of severe and persistent hypoglycemia in the neonatal period and early infancy and is characterized by an excessive or uncontrolled insulin secretion (inappropriate for the level of glycemia) and recurrent episodes of profound hypoglycemia requiring rapid and intensive treatment to prevent neurological sequelae. CHI comprises 2 different forms: diazoxide-sensitive diffuse hyperinsulinism and diazoxide-resistant hyperinsulinism."],"rawAttribution":"MONDO:0019010","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:39:06Z","upstream":"GARD:0003947","url":"https://rarediseases.info.nih.gov/diseases/3947"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"islet cell adenomatosis","mondoId":"MONDO:0007834","slug":null},{"kind":"parent","label":"familial hyperinsulinism","mondoId":"MONDO:0017182","slug":"familial-hyperinsulinism"},{"kind":"parent","label":"overgrowth syndrome","mondoId":"MONDO:0019716","slug":"overgrowth"},{"kind":"child","label":"hyperinsulinemic hypoglycemia, familial, 2","mondoId":"MONDO:0011153","slug":"hyperinsulinemic-hypoglycemia-familial-2"},{"kind":"child","label":"hyperinsulinemic hypoglycemia, familial, 3","mondoId":"MONDO:0011236","slug":"hyperinsulinemic-hypoglycemia-familial-3"},{"kind":"child","label":"diazoxide-sensitive diffuse hyperinsulinism","mondoId":"MONDO:0015624","slug":null},{"kind":"child","label":"diazoxide-resistant hyperinsulinism","mondoId":"MONDO:0017186","slug":"diazoxide-resistant-hyperinsulinism"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"multiple-identity-targets","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/congenital-hyperinsulinism"}],"translation":"pending"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/3947\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0019010\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0003947</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Congenital isolated hyperinsulinism (CHI), a rare endocrine disease is the most frequent cause of severe and persistent hypoglycemia in the neonatal period and early infancy and is characterized by an excessive or uncontrolled insulin secretion (inappropriate for the level of glycemia) and recurrent episodes of profound hypoglycemia requiring rapid and intensive treatment to prevent neurological sequelae. CHI comprises 2 different forms: diazoxide-sensitive diffuse hyperinsulinism and diazoxide-resistant hyperinsulinism.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/3947\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"congenital-isolated-hyperinsulinism","sourceDocuments":[{"name":"GARD: Congenital isolated hyperinsulinism","reviewed":null,"source_release":"2026-10-25T03:39:06Z","url":"https://rarediseases.info.nih.gov/diseases/3947"},{"name":"MONDO: congenital isolated hyperinsulinism","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0019010"}],"sourceNote":"","synonyms":["chi","congenital hyperinsulinism","hyperinsulinemic hypoglycemia familial","hyperinsulinism congenital","hyperinsulinism familial with pancreatic nesidioblastosis","hypoglycemia hyperinsulinemic of infancy","persistent hyperinsulinemic hypoglycemia of infancy","PHHI"],"takeawayHtml":"","title":"congenital isolated hyperinsulinism"},"schemaVersion":1}
